IRIS
LOGROSCINO, Giancarlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.894
EU - Europa 5.353
AS - Asia 4.485
AF - Africa 259
OC - Oceania 138
SA - Sud America 108
Continente sconosciuto - Info sul continente non disponibili 10
Totale 34.247
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.759
CN - Cina 1.644
SE - Svezia 1.023
SG - Singapore 885
IT - Italia 731
DE - Germania 721
UA - Ucraina 586
GB - Regno Unito 575
RU - Federazione Russa 446
FI - Finlandia 405
HK - Hong Kong 336
IN - India 292
FR - Francia 268
IR - Iran 223
KR - Corea 177
IE - Irlanda 131
VN - Vietnam 131
NL - Olanda 124
TW - Taiwan 122
AU - Australia 111
BE - Belgio 111
PK - Pakistan 104
CA - Canada 99
TR - Turchia 95
JP - Giappone 88
MY - Malesia 81
BR - Brasile 65
ID - Indonesia 50
BD - Bangladesh 44
ZA - Sudafrica 43
ET - Etiopia 40
IQ - Iraq 39
EG - Egitto 37
NG - Nigeria 37
SA - Arabia Saudita 34
CH - Svizzera 33
PH - Filippine 29
NO - Norvegia 27
NZ - Nuova Zelanda 27
GH - Ghana 25
AE - Emirati Arabi Uniti 23
ES - Italia 23
PL - Polonia 23
RO - Romania 22
TH - Thailandia 22
AT - Austria 17
MX - Messico 17
PT - Portogallo 17
EC - Ecuador 16
IL - Israele 15
CZ - Repubblica Ceca 14
MA - Marocco 12
CO - Colombia 10
DK - Danimarca 10
BW - Botswana 9
EU - Europa 9
GR - Grecia 9
NP - Nepal 9
BN - Brunei Darussalam 8
LT - Lituania 8
DZ - Algeria 7
KE - Kenya 6
LK - Sri Lanka 6
LY - Libia 6
PE - Perù 6
TN - Tunisia 6
CL - Cile 5
CR - Costa Rica 5
HU - Ungheria 5
MM - Myanmar 5
AL - Albania 4
BG - Bulgaria 4
JM - Giamaica 4
JO - Giordania 4
LS - Lesotho 4
NI - Nicaragua 4
RS - Serbia 4
ZM - Zambia 4
BH - Bahrain 3
BO - Bolivia 3
BT - Bhutan 3
GA - Gabon 3
HR - Croazia 3
LB - Libano 3
LU - Lussemburgo 3
BF - Burkina Faso 2
BJ - Benin 2
CM - Camerun 2
GT - Guatemala 2
KH - Cambogia 2
NA - Namibia 2
RW - Ruanda 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SO - Somalia 2
SV - El Salvador 2
TD - Ciad 2
UG - Uganda 2
VE - Venezuela 2
AZ - Azerbaigian 1
Totale 34.230
Salva come PNG Salva come JPEG
Città #
Fairfield 3.738
Woodbridge 2.499
Houston 2.036
Chandler 1.925
Ashburn 1.865
Seattle 1.543
Jacksonville 1.380
Cambridge 1.299
Wilmington 1.199
Ann Arbor 914
Nyköping 728
Singapore 675
Lawrence 444
Roxbury 434
Nanjing 359
Beijing 342
Des Moines 302
New York 228
Boardman 183
Hong Kong 154
San Diego 151
Princeton 135
Bari 129
Dublin 119
Santa Clara 105
Dearborn 100
Nanchang 96
Brooklyn 95
Los Angeles 92
Brussels 91
London 91
Shenyang 89
Paris 87
Dong Ket 86
Hebei 83
Inglewood 78
Jiaxing 77
Helsinki 70
Kuala Lumpur 61
Central 60
Tianjin 56
Munich 55
Changsha 53
Taranto 49
Tehran 46
Norwalk 45
Redwood City 45
Taipei 43
Guangzhou 39
Pune 39
Neunburg vorm Wald 38
Ruvo Di Puglia 38
Washington 38
Strasbourg 35
Melbourne 33
Tokyo 33
Toronto 30
Hefei 29
Milan 28
Shanghai 28
Istanbul 27
Frankfurt am Main 26
San Mateo 26
Liverpool 25
Accra 24
Berlin 24
Dhaka 24
Mumbai 24
Ostuni 24
Augusta 23
Jinan 23
Kunming 23
Leeds 23
San Jose 23
Ardabil 22
Auburn Hills 21
Falls Church 21
Hyderabad 21
Manchester 21
New Taipei 21
Sulaymaniyah 21
Lahore 20
San Francisco 20
Sydney 20
Brisbane 19
Chicago 19
Hanoi 19
Delhi 18
Leawood 18
Nowon-gu 18
Coventry 16
Jeddah 16
Leverkusen 16
Ningbo 16
Southwark 16
St Louis 16
Zhengzhou 16
Dubai 15
Isfahan 15
Islamabad 15
Totale 25.757
Salva come PNG Salva come JPEG
Nome #
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013 3.527
Prevalence of cognitive impairment and dementia in a population based study in Southern Italy: The Great Age study 265
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 240
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging 174
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 170
Age-related hearing impairment—a risk factor and frailty marker for dementia and AD 161
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 148
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 145
Comparative evaluation of two immunoassays for cerebrospinal fluid β-Amyloid 1–42 measurement 140
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 137
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 135
Social dysfunction in older age and relationships with cognition, depression, and apathy: The GreatAGE Study 135
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 134
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 132
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 131
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 130
Qualitative analysis of the capacity to consent to treatment in patients with a chronic neurodegenerative disease. Alzheimer's Disease. 129
Plasma β-amyloid 1–42 reference values in cognitively normal subjects 126
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial 124
Prefrontal activity and connectivity with basal ganglia during performance of complex cognitive tasks is associated with apathy in healthy subjects 123
Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort 122
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study 121
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 120
COGNITIVE-HD study: Protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis 120
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 119
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 118
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 118
Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres 116
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 114
Unreported financial disclosures in a study of migraine and cardiovascular disease 113
The prevalence of peripheral and central hearing impairment and its relation to cognition in older adults 113
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 113
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 110
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial 110
Evaluation of endothelial function and cardiovascular risk in non-obese patients with slight degree of obstructive sleep apnea syndrome 109
Bioelectrical correlates of emotional changes induced by environmental sound and colour: from virtual reality to real life 109
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease 109
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 108
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 108
The Role of Hearing Impairment in Cognitive Decline: Need for the Special Sense Assessment in Evaluating Cognition in Older Age 108
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 108
Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia 108
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 107
Epidemiology of age related hearing loss: A review 106
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 106
The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset 106
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 106
Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis 106
Factors predicting survival in ALS: a multicenter Italian study 105
Apolipoprotein E genotype does not influence the progression of multiple sclerosis 104
The age-related central auditory processing disorder: Silent impairment of the cognitive ear 104
Epidemiology of neurodegenerative diseases 104
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 103
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia 103
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 102
Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy 102
null 101
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 101
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke 101
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis 101
null 100
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. 100
Screening for aphasia in neurodegeneration for the diagnosis of patients with primary progressive aphasia: Clinical validity and psychometric properties 100
Cognitive frailty: a potential target for secondary prevention of dementia 98
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 97
Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis 95
null 95
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. 95
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial 94
Classification of healthy subjects and Alzheimer's disease patients with dementia from cortical sources of resting state EEG rhythms: A study using artificial neural networks 94
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 94
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 94
Metabolic syndrome, mild cognitive impairment, and dementia 93
Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases 93
Acute changes in blood-CSF barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation 92
A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy 92
Seborrheic dermatitis, increased sebum excretion, and Parkinson's disease: a survey of (im)possible links 91
Bipolar disorder and frontotemporal dementia: An intriguing association 91
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies 91
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 90
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 90
Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature 90
Accuracy of clinical diagnosis of Parkinson disease. A systematic review and meta-analysis 90
Agreement among neurologists on the clinical diagnosis of dystonia at different body sites 89
Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline 89
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 89
Age-specific ALS incidence: a dose–response meta-analysis 89
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy 88
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease. 88
Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis 88
The ever-stimulating association of smoking and coffee and Parkinson's disease 87
Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017 87
Long-term mortality after a first episode of status epilepticus 86
Environmental risk factors for Parkinson's disease in an urban multiethnic community 86
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 86
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 86
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 86
Response to Letter to the Editor: “Plasma β-amyloid1–42 reference values” 86
Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study 86
Migraine and risk of cardiovascular disease in women 85
Totale 14.408
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.404
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.998 0 0 0 0 0 628 932 882 1.121 487 712 236
2020/20215.788 395 341 406 554 646 392 831 440 466 640 357 320
2021/20222.953 148 179 21 133 165 347 78 157 249 214 433 829
2022/20234.730 721 468 304 426 560 546 96 566 796 38 133 76
2023/20244.498 347 627 357 335 425 1.095 484 440 88 44 51 205
2024/20252.849 250 224 904 473 254 744 0 0 0 0 0 0
Totale 35.634